Allogene Therapeutics (NASDAQ:ALLO) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.60) by 10 percent. This is a 1.89 percent decrease over losses of $(0.53) per share from the same period last year.
Why Barnes & Noble Education Shares Are Trading 30% Lower
Barnes & Noble Education Inc (NYSE: BNED) shares are trading lower by 29.41% to $1.80 Tuesday afternoon after the company reported worse-than-expected second-quarter adjusted EPS and sales results.
What Happened?
